Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Accept all cookies Reject all non-essential cookies Find out more

Enriching Engagement (Round 2) awardees announced

The awardees for the second round of the University of Oxford’s Enriching Engagement funding scheme have now been announced, including a project from Paediatrics.

Star-shaped trophy

Enriching Engagement is a Wellcome-funded grants programme open to Wellcome grant holders and awardees at the University of Oxford, to develop and deliver Public Engagement with Research projects. 

Round 2 awardees are:

  1. Dr Catherine Manning (Department of Experimental Psychology) -  "Sensory Street”
  2. Dr Jacinta O’Shea (Department of Psychiatry) - "Building stress resilience in early adolescence”
  3. Professor Anne Goriely (Weatherall Institute of Molecular Medicine, Radcliffe Department of Medicine) - “Me and my genome: What am I really made of?”
  4. Dr Carlo Rinaldi (Department of Paediatrics) - "Muscle Switch"
  5. Professor Jane Mckeating (Nuffield Department of Medicine) - "Understanding viruses: combining science and art to empower young people”
  6. Dr Anna Mitchell (Department of Experimental Psychology) - "APE: Animations and Public Engagement to promote transparency in primate neuroscience research”

Full details of each project are available on the University of Oxford website

Similar stories

A New Era for Childhood Cancer Research: Professor Isidro Cortés Ciriano Appointed as Oxford's First Little Princess Trust Professor of Paediatric Oncology

The Department of Paediatrics at the University of Oxford has appointed Professor Isidro Cortés-Ciriano as its first Little Princess Trust Professor of Paediatric Oncology, marking a major milestone in a partnership dedicated to accelerating the development of new treatments for children with cancer.

Oxford University and King’s College London Join IMPACT Network Study to Advance Understanding of Profound Autism

The University of Oxford and King’s College London (King’s) have joined the Innovative Medicine and Precision Approaches to Clinical Trials (IMPACT) Network, an international collaboration of sites working together to accelerate clinical trial readiness and therapeutic development for autism through a large-scale natural history and clinical endpoint study.

University of Oxford launches new public awareness campaign for Neurodevelopmental Disorders

The Department of Paediatrics at the University of Oxford today announces the launch of Genes, Brains, and Breakthroughs, a new educational campaign designed to raise public awareness and understanding of neurodevelopmental disorders through a series of accessible, family-informed video resources.

Breakthrough study moves newborn screening for SMA towards nationwide rollout

A major national study led by researchers in the Department of Paediatrics, to evaluate newborn screening for spinal muscular atrophy (SMA) has been funded by the National Institute for Health and Care Research (NIHR), marking a significant milestone towards the potential introduction of SMA screening across the UK.

Magdalen College lit up for Rare Disease Day

Magdalen College Chapel was lit up in the colours of Rare Disease Day last week, as part of the global Chain of Lights initiative.

World's first Phase II Nipah virus vaccine trial launch

The University of Oxford has launched the world’s first Phase II clinical trial of a Nipah virus vaccine candidate.

Similar stories

A New Era for Childhood Cancer Research: Professor Isidro Cortés Ciriano Appointed as Oxford's First Little Princess Trust Professor of Paediatric Oncology

The Department of Paediatrics at the University of Oxford has appointed Professor Isidro Cortés-Ciriano as its first Little Princess Trust Professor of Paediatric Oncology, marking a major milestone in a partnership dedicated to accelerating the development of new treatments for children with cancer.

Oxford University and King’s College London Join IMPACT Network Study to Advance Understanding of Profound Autism

The University of Oxford and King’s College London (King’s) have joined the Innovative Medicine and Precision Approaches to Clinical Trials (IMPACT) Network, an international collaboration of sites working together to accelerate clinical trial readiness and therapeutic development for autism through a large-scale natural history and clinical endpoint study.

University of Oxford launches new public awareness campaign for Neurodevelopmental Disorders

The Department of Paediatrics at the University of Oxford today announces the launch of Genes, Brains, and Breakthroughs, a new educational campaign designed to raise public awareness and understanding of neurodevelopmental disorders through a series of accessible, family-informed video resources.

Breakthrough study moves newborn screening for SMA towards nationwide rollout

A major national study led by researchers in the Department of Paediatrics, to evaluate newborn screening for spinal muscular atrophy (SMA) has been funded by the National Institute for Health and Care Research (NIHR), marking a significant milestone towards the potential introduction of SMA screening across the UK.

Magdalen College lit up for Rare Disease Day

Magdalen College Chapel was lit up in the colours of Rare Disease Day last week, as part of the global Chain of Lights initiative.

World's first Phase II Nipah virus vaccine trial launch

The University of Oxford has launched the world’s first Phase II clinical trial of a Nipah virus vaccine candidate.